Biocon secures $54m insulin tender in Malaysia
pre-market1 source ↓written by the desknot a recommendation
- from Malaysia’s Ministry
- $54 million
Biocon, in partnership with Duopharma Biotech, has been awarded three insulin contracts worth $54 million from Malaysia’s Ministry of Health. This deal enhances Biocon's presence in the Malaysian market and underscores its commitment to providing affordable insulin solutions.
The successful bid may strengthen investor sentiment and boost Biocon's revenue streams in the region.
Not investment advice. For informational purposes only.